U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H16N2.2ClH
Molecular Weight 249.18
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZYLPIPERAZINE DIHYDROCHLORIDE

SMILES

Cl.Cl.C(N1CCNCC1)C2=CC=CC=C2

InChI

InChIKey=BBUJLUKPBBBXMU-UHFFFAOYSA-N
InChI=1S/C11H16N2.2ClH/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13;;/h1-5,12H,6-10H2;2*1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H16N2
Molecular Weight 176.2581
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11.
2005 Dec 15
Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.
2005 Dec 16
Researching the toxicity of party pills.
2005 Dec-2006 Jan
Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector.
2005 Mar
Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers.
2005 May-Jun
Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.
2006 Jan-Feb
Copper(I) cyanide networks: synthesis, structure, and luminescence behavior. Part 2. Piperazine ligands and hexamethylenetetramine.
2008 Aug 4
Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
2008 Jul-Aug
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine.
2009 Apr
Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
2010 Dec
Purchasing 'legal highs' on the Internet--is there consistency in what you get?
2010 Jul
Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases: lead optimization studies toward the identification of an orally bioavailable preclinical development candidate.
2010 Jul 22
Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
2010 Mar
Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
2010 Oct
A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer.
2010 Oct 29
Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans.
2010 Sep
Estrogenic effects and their action mechanism of the major active components of party pill drugs.
2012 Nov 15
Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action.
2015 Dec
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 12:18:18 UTC 2023
Edited
by admin
on Sat Dec 16 12:18:18 UTC 2023
Record UNII
5CFGYMNN06
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZYLPIPERAZINE DIHYDROCHLORIDE
Common Name English
N-BENZYLPIPERAZINE DIHYDROCHLORIDE
Systematic Name English
1-BENZYLPIPERAZINE DIHYDROCHLORIDE
Systematic Name English
PIPERAZINE, 1-(PHENYLMETHYL)-, DIHYDROCHLORIDE
Systematic Name English
NSC-163993
Code English
PIPERAZINE, 1-(PHENYLMETHYL)-, HYDROCHLORIDE (1:2)
Systematic Name English
PIPERAZINE, 1-BENZYL-, DIHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
NSC
163993
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID20201294
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
FDA UNII
5CFGYMNN06
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
PUBCHEM
12198046
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
ECHA (EC/EINECS)
226-188-6
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
CAS
5321-63-1
Created by admin on Sat Dec 16 12:18:18 UTC 2023 , Edited by admin on Sat Dec 16 12:18:18 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY